Asking our natural cataract medicine for dogs and cats to work even harder at preventing and reversing cataracts is a mighty big ask.
But now, we've made our Primalix Cataractin even more effective with the addition of a simple amino acid that has been clinically proven to promote healthy vision and prevent vision disability from
Our new ingredient is N-acetyl L-carnosine (NALC), a naturally occurring amino acid and free radical scavenger found particularly active against lipid peroxidation in the eye lens.
A 1996 clinical study involving rabbit eyes treated with a 1% NALC solution proved NALC's effectiveness at treating ocular disorders originating from the component of oxidative stress, including
A 2002 clinical study using a 1% NALC solution treated 49 human subjects with 76 affected eyes. After 6 months, 90% of NALC-treated eyes showed improvement in best corrected visual acuity (7 to 100%) and 88.9% showed a 27 to 100% improvement in glare sensitivity.
Positive results from a 2004 study involving 90 canine eyes with cataracts evoked yet more chatter among researchers for yet "More studies!" In recent years the research world has crackled with news of one NALC study after another, inciting a crash of patent medicine applications for NALC-based ophthalmic products.
One clinical study published in the May 2009 issue of American Journal of Therapeutics was well summarized in a Smart-Publications article. Please note the article's incorrect use of the acronym NAC, which refers to N-acetyl L-cystein, instead of the correct NALC, which is N-acetyl L-carnosine.
In all NALC studies there were no reports of ocular or systemic adverse side effects. Our natural cataract medicine for dogs and cats, Primalix Cataractin, contains 1% NALC, the same strength used in clinical trials.
When taken orally as pets do with our Functional Food Drops, NALC is quicker and easier to digest, it's more stable and resists break down longer. This allows NALC to be carried throughout the body, asserting its powerful healing action as carnosine, in a prolongation of targeted physiological responses to the antioxidant therapy before being naturally separated into constituent amino acids, deactivated and eliminated. Conclusion: oral administration of NALC may be more efficacious than topical application.